Taxonomy of breast cancer based on normal cell phenotype predicts outcome

Sandro Santagata , Ankita Thakkar , Ayse Ergonul

The Journal of Clinical Investigation +

|

January 28, 2014

View abstract on PubMed

Summary

This study defines new breast tumor subtypes based on normal cell differentiation and hormone receptor expression, offering improved classification and insights into patient outcomes for breast cancer treatment.

Area Of Science

Oncology
Cell Biology
Endocrinology

Background

Accurate disease classification is crucial for understanding pathophysiology and guiding therapeutic decisions.
Current breast tumor classification relies on markers like estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2).
Limited understanding of epithelial cell differentiation compared to hematopoiesis has hindered solid tumor classification based on normal cell types.

Purpose Of The Study

To define subtypes of normal breast epithelial cells.
To classify human breast tumors based on normal cell differentiation and hormone receptor expression.
To investigate the association between these new subtypes and patient outcomes.

Main Methods

Systematic analysis of over 15,000 normal breast cells using a large set of breast epithelial markers.
Identification of 11 differentiation states for normal luminal breast cells.
Classification of 3,157 human breast tumors into 4 subtypes (HR0-HR3) based on vitamin D, androgen, and estrogen hormone receptor (HR) expression.

Main Results

Identified 11 distinct differentiation states in normal luminal breast cells.
Established a novel classification of breast tumors into 4 subtypes (HR0-HR3) based on hormone receptor expression.
Demonstrated that these HR subtypes are distinct from the current classification system.
Found that patient outcomes correlate with HR subtype, with HR3 (all 3 receptors) associated with the best outcomes and HR0 (no receptors) with the worst.

Conclusions

Developed an ontological classification scheme for breast tumors based on normal cell differentiation and hormone receptor expression.
This new classification correlates with significant differences in patient survival.
Provides actionable insights for the treatment of breast tumors.

Related Concept Videos